06.19.26 -- Inside AstraZeneca's Fully Electrified Cell Therapy Facility

Middlesex County, NJ, is a hotbed for the life sciences, offering a deep talent pool, an extensive R&D presence, and dedicated backing by local government in the form of strategic investment.

Explore the critical aspects of GMP-grade raw materials in CGT manufacturing, including contamination control, aseptic strategies, quality systems, supply chain security, and regulatory compliance.

Packaging is critical, as biotechnology products requiring colder storage become more valuable. Find out how you can improve your temperature-controlled supply chain and meet cold chain storage demands.

Amid the mRNA and oligonucleotide therapeutic boom, sponsors and manufacturers are uncovering how to make raw materials—capping agents, lipid nanoparticles, and RNA polymerase—more effective.

Gain insight into how to choose and validate normalization strategies for western blots, avoid common pitfalls, and ensure reproducible results using proteins tailored to your experimental context.

From high-dimensional profiling to customizable Omic panels, new technologies are redefining cell therapy development—delivering better insights, efficiency, and scalability for researchers worldwide.

Discover how closed-system approaches in HPAPI and ADC manufacturing reduce operator exposure, support Annex 1 alignment, and deliver labor savings of up to 90%.

Virtual process modeling is helping to cut production time, reduce solvent use, and improve sustainability. See how digital twins enable faster scale‑up decisions and more efficient manufacturing.

Achieving precise, site-specific conjugation on vaccine carrier proteins requires careful structural analysis to avoid disrupting critical functional regions and immune response pathways.

In this discussion, Dr. Alexis Santana explains what organoids are, how they are developed and applied, and why they are becoming a transformative tool in modern drug development.

Delve into how early stable CHO expression data reveals manufacturability issues in complex antibodies that transient screening misses, with case studies showing how this changes lead selection.

The peptide manufacturing industry is evolving to meet the demands of efficiency, scalability, and sustainability. Read about the latest innovations that are addressing these challenges.

Learn about a platform that addresses five critical pain points to help mRNA manufacturers flexibly scale while improving the digital maturity of their sites.

Examine why template sequence characteristics are relevant for cGMP manufacturing of high-quality mRNA and consider insights on how to develop a scalable, robust, and economically viable process.

Expression of inclusion bodies has historically suffered a bad reputation in the industry. So, how do these two routes, soluble and insoluble, compare in terms of their advantages and challenges?

Achieving desired glycosylation for therapeutic proteins can be difficult. Observe innovative approaches to optimize this critical quality attribute.

MISEV guidelines help extracellular vesicle researchers design robust experiments through transparent reporting and rigorous characterization rather than rigid checklists.

Understand the benefits of chemically defined media in E. coli systems, explore real-world plasmid DNA data, and learn practical strategies for scaling to robust manufacturing.